BCL2 and diffuse large B-cell lymphoma: Given the importance of release of BIM for apoptosis induction in DLBCL, these results suggested that BIM SAHBA was able to block endogenous BIM binding to MCL-1, BCL-2 and/or BCL-XL expressing cells regardless of their sensitivity to ABT-737/ABT-199.